The Drug-Induced Respiratory Disease Website and App

E-cigarette - E-vaporizers - ENDS - Vaping - Dabbing

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

X.q

Systemic inflammatory response

Publications

Cruz-Vidal DA, Mull ES, Taveras J, Shell R, Hunt GW, Fowler B, Wallihan R, Erdem G

EVALI versus MIS-C, one more overlapping diagnosis to consider.

Pediatric pulmonology 2021 09;56;2918-2924 — 2021 09 — 2918-2924

Hassoun A, Brady K, Arefi R, Trifonova I, Tsirilakis K

Vaping-Associated Lung Injury During COVID-19 Multisystem Inflammatory Syndrome Outbreak.

The Journal of emergency medicine 2021 04;60;524-530 — 2021 04 — 524-530